GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Captor Capital Corp (OTCPK:CPTRF) » Definitions » EBITDA Margin %

Captor Capital (Captor Capital) EBITDA Margin % : 3.21% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Captor Capital EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Captor Capital's EBITDA for the three months ended in Dec. 2023 was $0.22 Mil. Captor Capital's Revenue for the three months ended in Dec. 2023 was $6.98 Mil. Therefore, Captor Capital's EBITDA margin for the quarter that ended in Dec. 2023 was 3.21%.


Captor Capital EBITDA Margin % Historical Data

The historical data trend for Captor Capital's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Capital EBITDA Margin % Chart

Captor Capital Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -779.35 -253.00 -23.17 -36.10 -22.65

Captor Capital Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.82 -140.64 8.67 7.11 3.21

Competitive Comparison of Captor Capital's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Captor Capital's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Captor Capital's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Captor Capital's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Captor Capital's EBITDA Margin % falls into.



Captor Capital EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Captor Capital's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-6.927/30.577
=-22.65 %

Captor Capital's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=0.224/6.977
=3.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Captor Capital  (OTCPK:CPTRF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Captor Capital EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Captor Capital's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Captor Capital (Captor Capital) Business Description

Traded in Other Exchanges
Address
4 King Street West, Suite 401, Toronto, ON, CAN, M5H 1B6
Captor Capital Corp is a Canada based investment company which focuses on cannabis investments. It markets and supplies recreational cannabis products, as well as other high demand cannabis-based goods directly to California consumers through its CHAI Cannabis retail locations and online and delivery networks. The company's reportable segments are based upon the geographic region for its operations which include Canada, South Africa, Vietnam, and Cyprus.